On February 25, 2025, Envoy Medical, Inc. received a notification from Nasdaq stating it failed to meet the minimum market value requirement of $35 million for 31 consecutive business days from January 7 to February 24, 2025, and has until August 25, 2025, to regain compliance to avoid delisting.